BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 30858360)

  • 21. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
    Zhang Y; Li KF
    Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1α/CEACAM5 functional axis.
    Li Q; Li Y; Li J; Ma Y; Dai W; Mo S; Xu Y; Li X; Cai S
    Int J Biol Sci; 2018; 14(7):726-735. PubMed ID: 29910683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer.
    Zhou Y; Wu J; Fu X; Du W; Zhou L; Meng X; Yu H; Lin J; Ye W; Liu J; Peng H; Liu RY; Pan C; Huang W
    Mol Cancer; 2014 Nov; 13():258. PubMed ID: 25431208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7.
    Li X; Wang J; Zhang C; Lin C; Zhang J; Zhang W; Zhang W; Lu Y; Zheng L; Li X
    J Pathol; 2018 Oct; 246(2):166-179. PubMed ID: 29943828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.
    Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X
    Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth characteristics of HCT116 xenografts lacking asparagine synthetase vary according to sex.
    Aladelokun O; Lu L; Zheng J; Yan H; Jain A; Gibson J; Khan SA; Johnson CH
    Hum Genomics; 2024 Jun; 18(1):67. PubMed ID: 38886847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIF-1α induced lncRNA LINC00511 accelerates the colorectal cancer proliferation through positive feedback loop.
    Sun S; Xia C; Xu Y
    Biomed Pharmacother; 2020 May; 125():110014. PubMed ID: 32092829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-29b suppresses proliferation and mobility by targeting SOX12 and DNMT3b in pancreatic cancer.
    Wang L; Wang Z; Huang L; Wu C; Zhang B
    Anticancer Drugs; 2019 Mar; 30(3):281-288. PubMed ID: 30601190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
    Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B7-H4 induces epithelial-mesenchymal transition and promotes colorectal cancer stemness.
    Feng Y; Yang Z; Zhang C; Che N; Liu X; Xuan Y
    Pathol Res Pract; 2021 Feb; 218():153323. PubMed ID: 33429327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
    Wang S; Qiu J; Liu L; Su C; Qi L; Huang C; Chen X; Zhang Y; Ye Y; Ding Y; Liang L; Liao W
    J Exp Clin Cancer Res; 2020 Aug; 39(1):168. PubMed ID: 32843066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel evidence for oncogenic piRNA-823 as a promising prognostic biomarker and a potential therapeutic target in colorectal cancer.
    Feng J; Yang M; Wei Q; Song F; Zhang Y; Wang X; Liu B; Li J
    J Cell Mol Med; 2020 Aug; 24(16):9028-9040. PubMed ID: 32596991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of Zinc-finger protein X-linked promotes tumor growth and predicts a poor outcome for stage II/III colorectal cancer patients.
    Yan X; Shan Z; Yan L; Zhu Q; Liu L; Xu B; Liu S; Jin Z; Gao Y
    Oncotarget; 2016 Apr; 7(15):19680-92. PubMed ID: 26967242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation.
    Liu C; Wang L; Liu X; Tan Y; Tao L; Xiao Y; Deng P; Wang H; Deng Q; Lin Y; Jie H; Zhang H; Zhang J; Peng Y; Zhang H; Zhou Z; Sun Q; Cen X; Zhao Y
    Theranostics; 2021; 11(6):2966-2986. PubMed ID: 33456583
    [No Abstract]   [Full Text] [Related]  

  • 36. Decreased expression of miR‑490‑3p in colorectal cancer predicts poor prognosis and promotes cell proliferation and invasion by targeting RAB14.
    Wang B; Yin M; Cheng C; Jiang H; Jiang K; Shen Z; Ye Y; Wang S
    Int J Oncol; 2018 Sep; 53(3):1247-1256. PubMed ID: 29916545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1/2 pathways.
    Tao Y; Han T; Zhang T; Sun C
    Biomed Pharmacother; 2017 May; 89():1370-1377. PubMed ID: 28320104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FOXC2 promotes colorectal cancer metastasis by directly targeting MET.
    Cui YM; Jiao HL; Ye YP; Chen CM; Wang JX; Tang N; Li TT; Lin J; Qi L; Wu P; Wang SY; He MR; Liang L; Bian XW; Liao WT; Ding YQ
    Oncogene; 2015 Aug; 34(33):4379-90. PubMed ID: 25381815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF-1α activates hypoxia-induced BCL-9 expression in human colorectal cancer cells.
    Tan Z; Huang Q; Zang J; Teng SF; Chen TR; Wei HF; Song DW; Liu TL; Yang XH; Fu CG; Hu ZQ; Zhou W; Yan WJ; Xiao JR
    Oncotarget; 2017 Apr; 8(16):25885-25896. PubMed ID: 27121066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.